SN

Shimoga Nagendrashetty Sheethal

Active Director Designated Partner DIN 11580894
DIN 11580894 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shimoga Nagendrashetty Sheethal

Data last updated:

Shimoga Nagendrashetty Sheethal is a Designated Partner at Arcs Biotech Llp (since 2026).

DIN 11580894
Primary Designation Designated Partner
First Appointment 02 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arcs Biotech Llp ACV-9019
Designated Partner02 Mar 20262026Active

Board colleagues of Shimoga Nagendrashetty Sheethal

NameDINCompanyDesignation
Bandekodigena Halli Suresha Adithya Kashyap11580892Arcs Biotech LlpDesignated Partner
Chaitra Suresh11580893Arcs Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Arcs Biotech Llp
Premium access

Shareholding and investment profile for Shimoga Nagendrashetty Sheethal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shimoga Nagendrashetty Sheethal

Shimoga Nagendrashetty Sheethal currently holds 1 directorship: Arcs Biotech Llp (Designated Partner, since 02 Mar 2026).

Shimoga Nagendrashetty Sheethal was first appointed on 02 Mar 2026 as Designated Partner at Arcs Biotech Llp.

The current boards of Shimoga Nagendrashetty Sheethal's companies include Bandekodigena Halli Suresha Adithya Kashyap (Arcs Biotech Llp), Chaitra Suresh (Arcs Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available